Flavoring tablets

Abstract

(i) Carrier and (ii) Flavor composition A flavoring tablet containing or comprising (a) The carrier is a water-soluble powder, (b) The fragrance composition is (b1) at least one fragrance ingredient; (b) at least one solubilizing agent; and (b3) at least one pH adjuster A fragrance tablet containing or consisting of is proposed.

Description

Technical Field

[0001] The present invention relates to the field of fragrances, and discloses a fragrance tablet applicable to personal care.

Background Art

[0002] The 21st century is also called the era of hedonism, and both men and women attach great importance to their appearance. This means not only wearing favorable clothing, but also wearing a scent suitable for any occasion to emphasize the desired impression on others. Just as these occasions are different, the fragrances that convey messages are also varied. In the morning at the start of a working day, it can be a youthful and fresh scent; in the afternoon, it can be a sporty scent; while in the evening, it can be a rich and full-bodied scent. Of course, consumers can meet this demand by freely using different scents according to different occasions.

[0003] However, the range of scents created by perfumers seems to be endless. New creations continue to enter the market, replacing poorly-selling products and seeking their own niches. However, the huge variety of products makes it difficult for consumers to make choices. Perfume is often a high-end product, and consumers usually only keep a small number of perfumes at home. Purchasing a new, possibly unfamiliar product that eventually does not match one's preference and will be discarded sooner or later is a costly matter and not sustainable.

[0004] Therefore, the market has long been interested in being able to sell multiple scents to consumers at the same time with a single purchase decision. Previously, this problem has been solved by ensembles of various famous scents, which are bottled as miniatures of original small bottles and sold together. This solution is of course very complex and expensive, and has not been established in the market. Another similarly well-known practice is putting various perfumes into inconspicuous spray containers of a few milliliters, which perfume shops give to customers as "samples" when customers purchase other products. However, this can only arouse customers' interest.

[0005] Therefore, there remains a market need for new forms of fragrance offerings that possess highly individualized characteristics and, above all, allow consumers to select the most suitable fragrance for a particular occasion from a wide range of perfumes, without having to stockpile a large number of different fragrances for this purpose.

[0006] Further issues with perfumes and fragrances are their stability and solubility. Therefore, fragrance compositions generally contain ethanol, which contributes to the solubility of the fragrance ingredients and, consequently, their stability. However, excessive use of ethanol on human skin can damage the skin's own substances that maintain skin health. Furthermore, alcohol has astringent properties and can dry out the skin. Therefore, there is a market need for fragrance compositions that do not contain ethanol.

[0007] International Publication No. 1993 / 008255 (HENKEL) relates to tablets, particularly for washing and rinsing baths of textiles, in which sorbite is used as a carrier and carbonates and acids are used as gas release systems. These tablets contain a large amount of fragrance and are storage stable, but they disintegrate very quickly in water.

[0008] U.S. Patent No. 4,196,851 (TREASURE MASTERS) requests a porous pouch tablet prepared by compression molding or tableting a powder prepared by mixing insoluble tribasic calcium phosphate with a small amount of soluble sodium hexametaphosphate, binding it with a small amount of food starch, and internally lubricating the powder with fatty acid soap, preferably magnesium stearate, to aid in tableting. The tablet or blank is preferably prepared by slurring the phosphate and binder in water, spray-drying the slurry, dry-mixing the lubricant, and compression molding. The tablet is then moistened with a perfume of the desired scent to obtain a pouch tablet.

[0009] U.S. Patent Application Publication No. 2005 / 049154 (BRADY) discloses a fragrance formulation that uses an effervescent agent to release a fragrance from a non-shattering, conical release tablet.

[0010] U.S. Patent Application Publication No. 2010 / 0166816 (ZOBELE) relates to a tablet for holding volatile substances, such as perfumes and / or insecticides, in a liquid or solid state. The tablet comprises at least first and second layers of a volatile substance-holding material, the first and second layers being spaced apart from each other at a selected distance, and further comprising a layer of impermeable material bonded to the layers and located between the first and second layers.

[0011] U.S. Patent Application Publication No. 2013 / 165366 (SLABODEN) relates to a fragrance tablet having a fragrance selected from the group consisting of synthetic fragrances, natural fragrances, and essential oils, and a fragrance tablet dispensing device, wherein the fragrance tablet dispensing device is water-soluble, and related methods are disclosed. The fragrance tablet dissolves in laundry water and is mixed with unscented laundry detergent to produce a desired fragrance.

[0012] Chinese Patent No. 115779126 (GUANGZHOUXUELEI) provides a long-acting fragrance tablet comprising a base material and a fragrance liquid, and a method for preparing the same. The fragrance liquid comprises the following raw materials: anhydrous ethyl alcohol, glycerol, sweet-scented osmanthus extract, turmeric extract, Murraya paniculata extract, sodium alginate, surfactant, jojoba oil, essential oil, and water. [Prior art documents] [Patent Documents]

[0013] [Patent Document 1] International Publication No. 1993 / 008255 [Patent Document 2] U.S. Patent No. 4196851 [Patent Document 3] U.S. Patent Application Publication No. 2005 / 049154 [Patent Document 4] U.S. Patent Application Publication No. 2010 / 0166816 [Patent Document 5] U.S. Patent Application Publication No. 2013 / 165366 [Patent Document 6] Chinese Patent No. 115779126 Specification [Overview of the initiative] [Problems that the invention aims to solve]

[0014] Therefore, the fundamental problem of the present invention was to provide a new dosage form of fragrance composition that enables the individual production of single-use perfumes. The objective was to design the dosage form such that the fragrance composition exists in an encapsulated form, thereby allowing the capsule to be stable for a long period of time against the filler, while simultaneously being rapidly and completely soluble in water. Another objective was to provide a dosage form that does not contain ethanol, can be easily converted into an applicable product by mixing with water, and does not require additional packaging to improve the sustainability of the product. [Means for solving the problem]

[0015] The first object of the present invention is, (i) Carrier and (ii) Flavor composition A flavoring tablet containing or comprising (a) The carrier is a water-soluble powder, (b) The fragrance composition (b1) at least one fragrance ingredient; (b) at least one solubilizing agent; and (b3) at least one pH adjuster This relates to flavor tablets containing or consisting of [a certain substance].

[0016] The present invention provides a packaged fragrance sufficient for one-time use. For this purpose, the tablet is placed in water, where the fragrance composition dissolves almost instantaneously. The aqueous fragrance solution obtained in this way can be applied to the skin and hair like a perfume, and can also be used to impart fragrance to textiles and hard surfaces. A particular advantage is that one sales container contains single-use tablets, and each unit contains a different fragrance, allowing for appropriate selection. Furthermore, since the tablets do not contain ethanol and do not require additional packaging, they support sustainability from an environmental perspective.

[0017] Surprisingly, the applicant has found that a fragrance composition, preferably an ethanol-free fragrance composition, can be stably compressed into tablets when the fragrance composition also contains a solubilizer and a pH adjuster. Otherwise, the tablets will deteriorate in appearance and disintegrate at an early stage. Another advantage is that since the tablet dissolves completely, no waste remains. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] [Figure 1] Figure 1 shows a manual tableting press. [Figure 2] Figure 2 shows an exemplary fragrance tablet of the present invention. MODE FOR CARRYING OUT THE INVENTION

[0019] <Carrier> Suitable carriers constituting component (a) are solid, and include granules, preferably water-soluble powders. Water-soluble means that at least 100 g of the carrier completely dissolves in 1 L of water (20 dH, 20°C) in less than 1 minute. Preferably, the carrier is selected from the group consisting of maltodextrin, sorbitol, talc, hydrolyzed starch, hydroxypropyl cyclodextrin, xylitol, starch, tapioca clay, microcrystalline cellulose and mixtures thereof. It has been found advantageous to use a carrier in powder form, wherein the powder exhibits an average particle size ranging from about 100 to about 500 μm, particularly from about 150 to about 400 μm.

[0020] <Fragrance raw materials> Therefore, the "fragrance raw material" in the sense of the present invention that constitutes compound (b1) is any raw material that provides a fragrance or contributes to a good fragrance in the final blend of many fragrance raw materials. The term "fragrance raw material" also includes scented raw materials and solvents that enhance the intensity of other fragrance raw materials. Particularly preferred fragrance raw materials include all raw materials used in a fragrance composition that provide fragrance or effect to a combination of raw materials.

[0021] In preferred embodiments, the fragrance raw material is selected from the group consisting of acetals, acids, alcohols, aldehydes, amides, amines, essential oils, esters, ethers, heterocyclic compounds, hydrocarbons, ketones, lactones, nitriles, nitro compounds, oximes, phenols, and mixtures thereof.

[0022] However, the properties of the fragrance ingredients that make up the most important part of the pod are not important. Basically, all types of fragrance ingredients are suitable for encapsulation, and typically include fragrance mixtures containing 50, 70, 100 or more individual fragrance ingredients. Suitable fragrances and oils can be selected from the following group: ·alcohol ·aldehyde • Amines, amides, nitriles ·ester ·ether • Ketones Lactone • and mixtures thereof.

[0023] Below, these groups are described with various examples, distinguishing between fragrances or perfumes known to experts by their trade names or common names.

[0024] (alcohol) The following table shows suitable alcohols known to experts by their brand names. [Table 1]

[0025] The following table lists suitable alcohols known by their common names to experts. [Table 2]

[0026] (aldehyde) The following table shows suitable aldehydes known by trade names to experts. [Table 3]

[0027] [Table 4]

[0028] Furthermore, the following table shows aldehydes that are known by their common names to experts. [Table 5]

[0029] (Amines, amides, and nitriles) The following table lists suitable amines, amides, and nitriles known to experts by trade names or common names. [Table 6]

[0030] (ester) The following table shows suitable esters known by trade names to experts. [Table 7]

[0031] The following table shows suitable esters known by their common names to experts. [Table 8]

[0032] [Table 9]

[0033] (ether) The following table shows suitable ethers known to experts by trade names. [Table 10]

[0034] The following table shows suitable ethers known by common names among experts. [Table 11]

[0035] (Ketones) The following table shows suitable ketones known by trade names to experts. [Table 12]

[0036] The following table shows suitable ketones known by their common names to experts. [Table 13]

[0037] (Lactone) The following table shows suitable lactones known by trade names to experts. [Table 14]

[0038] Furthermore, the following table shows lactones that are known by their common names to experts. [Table 15]

[0039] (Essential oils and extracts) Suitable fragrances and oils are shown in the table below. [Table 16]

[0040] [Table 17]

[0041] [Table 18]

[0042] [Table 19]

[0043] In a preferred embodiment of the present invention, the fragrance composition comprises at least one fragrance ingredient in an amount of about 3 to about 205% by weight. In a more preferred embodiment of the present invention, the fragrance composition comprises at least one fragrance ingredient in an amount of about 5 to about 15% by weight.

[0044] Preferably, a mixture of at least two fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least three fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least four fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least five fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least six fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least seven fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least eight fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least nine fragrance ingredients is used in the fragrance composition. More preferably, a mixture of at least ten fragrance ingredients is used in the fragrance composition.

[0045] <Solubilizer> Of particular importance to the present invention is that a tablet spontaneously and clearly dissolves immediately upon being introduced into water. On the other hand, the tablet must also have sufficient stability to prevent disintegration in its dosage form. When selecting a carrier, emphasis is often placed on tablet stability, so it is effective to add excipients that conversely promote dissolution rate. In the first embodiment of the present invention, these solubilizers may be alkanediols, preferably 1,2-alkanediols having 5 to 12 carbon atoms.

[0046] Said 1,2-alkanediol can be selected from the group consisting of ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, diethylene glycol, dipropylene glycol, triethylene glycol, polyethylene glycol, 1,2-butanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, 1,2-decanediol, 1,2-undecanediol, 1,2-dodecanediol, 1,2-tetradecanediol or mixtures thereof. 1,3-pentanediol and 1,4-pentanediol are also suitable humectants.

[0047] In another preferred embodiment, the solubilizer is C5-C 12 selected from the group consisting of alkyl glycosides; particularly preferred are pentyl glucoside, hexyl glucoside, heptyl glucoside and octyl glucoside.

[0048] In another preferred embodiment, the solubilizer can be selected from the group consisting of PEG 40 hydrogenated castor oil, trideceth-9, polyglyceryl-6 caprylate, polysorbate 20, polysorbate 80, sodium cocoyl glutamate, polyglyceryl-6 oleate, sodium surfactin, polyglyceryl-4 caprate and mixtures thereof.

[0049] <pH adjuster> pH adjusters are the third essential compound (b3) of the fragrance composition and are important for the stability of the tablets. They can be selected from the group consisting of sodium chloride, citric acid, sodium benzoate, triethyl citrate, triethanolamine, potassium sorbate, aminocitric acid, adipic acid, and mixtures thereof.

[0050] <Tablet composition> In a preferred embodiment, the fragrance composition contains at least 35% by weight, preferably about 40 to about 55% by weight, of a water-soluble carrier.

[0051] More preferably, the tablet contains the carrier and the fragrance composition in a weight ratio of about 1:1 to about 1:100, preferably about 1:2 to about 1:20.

[0052] In another preferred embodiment, the tablet of the present invention is (a) A carrier of approximately 35 to 55% by weight, preferably about 40 to 50% by weight; (b1) At least one fragrance ingredient in an amount of approximately 3 to approximately 20% by weight, preferably approximately 5 to approximately 15% by weight; (b2) at least one solubilizing agent in an amount of about 5 to about 25% by weight, preferably about 10 to about 22% by weight; and (b3) comprising or consisting of at least one pH adjusting agent in an amount of about 15 to about 35% by weight, preferably about 20 to about 30% by weight, totaling 100% by weight.

[0053] Those skilled in the art will know that if only components (a), (b1), (b2), and (b3) constitute a tablet composition, the total amount of these components must be 100% by weight. For the sake of clarity, it should be emphasized that compositions that do not amount to 100% by weight are outside the scope of this invention. However, as stated above, those skilled in the art will be able to identify compositions in accordance with the above technical teachings without any additional inventive steps.

[0054] It should also be noted that preferred ranges and subranges of components (a), (b1), (b2), and (b3) can be combined.

[0055] In a more preferred embodiment of the present invention, the fragrance composition does not contain ethanol. As already mentioned, this has many advantages not only from a cosmetic standpoint but also from a sustainability standpoint.

[0056] Preferably, the tablets dissolve completely in water with a hardness of 16 dH ("Deutsche Haerte") at 20°C when the weight ratio of the tablets to water is in the range of about 1:8 to about 1:3, preferably about 1:5 to about 2:7.

[0057] <Manufacturing method> Another object of the present invention relates to a method for producing a flavor tablet, comprising or consisting of the following steps: (a) A step of preparing a solid carrier; (b) A step of preparing a mixture of at least one fragrance ingredient, at least one solubilizer, and at least one pH adjuster; (c) Blending the compounds from steps (a) and (b) under stirring at a temperature in the range of approximately 30 to approximately 50°C; (d) A step of subjecting the mixture from step (c) to a mechanical press to obtain the final product.

[0058] The order of the processes, and especially the heating process, is extremely important. For example, if the blend is not heated, the resulting tablets will dissolve and become a cloudy solution.

[0059] Details of the preparation are also described in the experimental section. The tablets obtained in this way exhibit high solubility and dissolve completely in water with a hardness of 16 dH at 20°C, preferably in a weight ratio of tablets to water in the range of about 1:8 to about 1:3, preferably in the range of about 1:4 to about 2:7. [Industrial applicability]

[0060] Finally, another object of the present invention relates to the use of the tablets of the present invention for personal care applications, namely for the individual application of fragrances to the skin and hair. [Examples]

[0061] <General preparation procedure for flavored tablets> This method includes the following steps: (i) A step of preparing a solid carrier; (ii) A step of preparing a mixture of at least one fragrance ingredient, at least one solubilizer, and at least one pH adjuster; (iii) Blending the compounds from steps (i) and (ii) under stirring at a temperature in the range of approximately 30 to approximately 50°C; (iv) A step of transferring the mixture from step (iii) to a tablet press to obtain the final product.

[0062] A suitable manual tablet press is shown in Figure 1. Figure 2 shows a typical flavored tablet of the present invention.

[0063] <Examples 1-6> (Soluble properties of the carrier) Various water-soluble powders were blended with water and stirred at 20°C for 10 seconds. The results are shown in Table 1. [Table 20]

[0064] <Examples 7-12> (Absorption of fragrance onto carrier in the absence of a solubilizer) Various water-soluble powders were treated with standard fragrance compositions. Absorption was assessed on the following scale: (+) = acceptable, (++) = good, (+++) = perfect. The results are shown in Table 2. [Table 21]

[0065] <Examples 13-18> (Absorption of fragrance onto carrier in the presence of a solubilizer) Various water-soluble powders were treated with standard fragrance compositions. Absorption was assessed on the following scale: (+) = acceptable, (++) = good, (+++) = perfect. The results are shown in Table 3. [Table 22]

[0066] <Examples 19-23> (Solubilizing power) Aqueous solutions of fragrance and solubilizer were prepared. The results are shown in Table 4. [Table 23]

Claims

1. (i) carrier and (ii) Flavor composition A flavoring tablet containing or comprising (a) The carrier is a water-soluble powder, (b) The fragrance composition is (b) at least one fragrance ingredient; (b) at least one solubilizing agent; and (b3) at least one pH adjuster A flavoring tablet containing or consisting of [the specified ingredient].

2. The tablet according to claim 1, wherein the carrier is selected from the group consisting of maltodextrin, sorbitol, talc, hydrolyzed starch, hydroxypropyl cyclodextrin, xylitol, starch, tapioca clay, microcrystalline cellulose, and mixtures thereof.

3. The aforementioned fragrance ingredients are ·alcohol, ·aldehyde, • Amines, amides, nitriles, ·ester, ·ether, ・Ketones, Lactone A tablet according to claim 1, selected from the group consisting of and mixtures thereof.

4. The aforementioned fragrance or fragrance oil is 1-(2-tert-butylcyclohexyl)oxybutan-2-ol (139504-68-0; Amber core); 2,6-di-tert-butyl-p-cresol (128-37-0; BHT Ionol); (Z)-3-methyl-5-(2,2,3-trimethyl-1-cyclopenta-3-enyl)penta-4-en-2-ol (67801-20-1; Ebanol); 4-methyl-2-(2-methylpropyl)oxan-4-ol (63500-71-0; Florosa / Pyranol); [(1R,2S)-1-methyl-2-[[(1R,3S,5S)-1,2,2-trimethyl-3-bicyclo[3.1.0]hexanyl]-methyl]cyclopropyl]methanol (198404-98-7; Javanol); (3R)-1-[(1R,6S)-2,2,6-trimethylcyclohexyl]hexane-3-ol; (3S)-1-[(1R,6S)-2,2,6-trimethylcyclohexyl]hexane-3-ol (70788-30-6; Norlimbanol); 3-methyl-5-phenylpentan-1-ol (55066-48-3; Phenoxanol); (E)-3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol (107898-54-4; Polysantol); 5-(3-methylphenyl)pentan-1-ol (25634-93-9; Rosaphen); 3-methyl-5-(2,2,3-trimethylcyclopenta-3-en-1-yl)pentan-2-ol (1471313-03-7; 65113-99-7; Sandalore); (2E)-2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-buten-1-ol + 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol (106 185-75-5; 28219-61-6; Sandranol); (E)-4-methyldeca-3-en-5-ol (81782-77-6; Undecavertol); 3-[5,5,6-trimethylbicyclo[2.2.1]hepta-2-yl]cyclohexane-1-ol (70955-71-4; Sandela); hexane-1-ol; octan-1-ol; decane-1-ol; dodecane-1-ol; borneol; isoborneol; citronellol; L-citronellol; dihydroeugenol; dihydromyrcenoyl; dimethylbenzylcarbinol; ethyllinalool; eugenol; geraniol; cis-3-hexenol; isobornylcyclohexanol; linalool; nerolidol; A tablet according to any one of claims 1 to 3, selected from the group of alcohols consisting of phenylethyl alcohol; phenylethyldimethylcarbinol; phenylpropyl alcohol; propenylguaetol; sulfolol; α-terpineol; tetrahydrolinalool; thymol; and mixtures thereof.

5. The aforementioned fragrance or fragrance oil is 2,6,10-trimethylundeca-9-enal (141-13-9; Adoxal; Farenal); α-3,3-trimethylcyclohexanemethanol formate (25225-08-5; Aphermate); 4-(1,1-dimethylethyl)-benzenepropanal (18127-01-0; Bourgeonal); 6-methoxy-2,6-dimethyloctanal (929253-05-4; Calypsone); 4-methoxy-α-methylbenzenepropanal (5462-06-6; Canthoxal); α,2,2,6-tetramethylcyclohexenebutanal (65405-84 -7; Cetonal); 8,8-dimethyl-1,2,3,4,5,6,7,8-octahydro-2-naphthaldehyde + 1,2,3,4,5,6,7,8-octahydro-5,5-dimethyl-2-naphthalenecarboxaldehyde (68991-96-8; 68991-97-9; Cyclomyral); 4-(octahydro-4,7-methano-5H-idene-5-ylidene)butanal (30168-23-1; Dupical); 4,8-dimethyl-4,9-decadienal (71077-31-1; Floral) Super); 3-(4-ethylphenyl)-2,2-dimethylpropanal + 3-(2-ethylphenyl)-2,2-dimethylpropanal (67634-15-5; 67634-14-4; Florazon); β-methyl-3-(1-methylethyl)-benzenepropanal (12509-85-5; Florhydral); methylenedioxyphenyl-methylpropanal (1205-17-0; Helional); α,4-dimethylbenzenepropanal (41496-43-9; Jasmorange, Satinaldehyde); (Z,E)-2,4-dimethylcyclohexa-3-ene-1-carbaldehyde (68039-49-6; 68737-61-1; Ligustral, Tripalal, Cyclal C, Vertocitral); 3-(4-tert-butylphenyl)butanal (80-54-6; Lilial); (1R)-β,4-dimethyl-3-cyclohexene-1-propanal (199445-85-7; Liminal);(4R)-4-(1-methylethyl)-1-cyclohexene-1-propanal (1378867-81-2; Lilybelle); (4S)-4-(1-methylethyl)-1-cyclohexene-1-propanal (1378867-82-3; Lilybelle Isomer); 4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-1-carboxaldehyde (130066-44-3; Lyral); 6-methyl-1-8-yl-methyleth-I-bicyclo[2.2.2]octa-5-ene-2-carboxaldehyde (67845-30-1; Maceal); (±)-2,6-dimethyl-5-heptenal (106-72-9; Melonal); (E)-2,6,10-trimethylundenal Car-5,9-Dienal (54082-68-7; Oncidal); 6,6-Dimethyl-2-Norpinene-2-Propionaldehyde (33885-51-7; Pinoacetaldehyde); 1-Methyl-4-(4-Methyl-3-Pentenyl)Cyclohexa-3-ene-1-Carboxaldehyde + 6,6-Dimethyl-2-Norpinene-2-Propionaldehyde (119652-81-2; 52475-86-2; Precyclemone) B); 3-phenylbutanal (16251-77-7; Trifernal); octahydro-5-methoxy-4,7-methano-1H-indene-2-carboxaldehyde (86803-90-9; Scentenal); rel-(3aR,4R,5R,7R,7aR)-octahydro-4,7-methano-1H-indene-5-carboxaldehyde (145374-28-3; Vertral); 4-(4-methylpenta-3-enyl)cyclohexa-3-ene-1-carbaldehyde (37677-14-8; Vertomugal; Hexanal; Heptanal; Octanal; 2-nonen-1-al; Nonanal; Decanal; Undecenal; 2-Methyldecanal; 10-Undecenal; Undecenal; Dodecanal; 2-Methylundecenal; Anisaldehyde; Benzaldehyde; Citral; Citronellal; Cinnamaldehyde; Cuminaldehyde; Cyclamenaldehyde; Dihydrocitronellal; Trans-2-Dodecanal; Ethylvanillin; Geranial; Heliotropin / Piperonal;A tablet according to any one of claims 1 to 4, selected from the group of aldehydes consisting of trans-2-hexenal; α-hexyl cinnamaldehyde; hydratropic aldehyde; hydroxycitronellal; isocyclocitral; methoxycitronellal; neral; phenylacetaldehyde; tangerine; cyclamen homoaldehyde; vanillin; and mixtures thereof.

6. The aforementioned fragrances or fragrance oils include 3,7-dimethylocta-6-ennitrile (51566-62-2; Argunitril); (E / Z)-3-methyl-5-phenylpenta-2-ennitrile (53243-59-7; 53243-60-0; 93893-89-1; Citronitrile); 3,7-dimethylnona-2,6-diennitrile (61792-11-8; Lemonile); 4-[(3E)-4,8-dimethylnona-3,7-dienyl]pyridine (38462-23-6; Maritima); trideca-2-ennitrile (22629-49-8; Ozonil); 2-cyclohexylidene-2-phenylacetonitrile (10461-98-0; A tablet according to any one of claims 1 to 5, selected from the group of amines, amides, and nitriles, comprising peonile; indole; and mixtures thereof.

7. The aforementioned fragrance or fragrance oil is cis-2-tert-butylcyclohexyl acetate + (2-tert-butylcyclohexyl) acetate (20298-69-5; 88-41-5; Argumex HC / LC); ethyl-3-methyl-3-phenyloxiran-2-carboxylate (77-83-8; aldehyde C16); propane-2-enyl-2-cyclohexyloxyacetate (68901-15-5; Cyclogalbanat); methyl-2,4-dihydroxy-3,6-dimethylbenzoate (4707-47-5; Evernyl); 4-methylpentan-2-yl(E)-buta-2-enoate (35206-51-0; Frutinat); ethyl-2-e Tyl-6,6-dimethylcyclohexa-2-ene-1-carboxylate (57934-97-1; 77851-07-1; Givescone); methyl-3-oxo-2-pentylcyclopentaneacetate (24851-98-7; Hedione); 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methylpropylpropanoate (141773-73-1; Helvetolide); 3a,4,5,6,7,7a-hexahydro-4,7 -methanoindene-6-ylacetate (5413-60-5; Herbalflorat); 3a,4,5,6,7,7a-hexahydro-4,7-methanoindene-6-ylacetate (5413-60-5; Herbalflorat); [(Z)-hexa-3-enyl]methyl carbonate (67633-96-9; Leafovert); ethyl 2-methylpentanoate (39255-32-8; Manzanate); 2-[1-(3,3-dimethylcyclohexyl [Ethoxy]-2-oxoethylpropionate (236391-76-7; Romandolide); Ethyl-2-cyclopenta-2-ene-1-ylacetate (15848-49-4; Sultanene); (1S,2R,5S)-5-methyl-2-(1-methylethyl)-cyclohexanol acetate + [(1R,2S,5R)-5-methyl-2-propane-2-ylcyclohexyl)]-acetate (29066-34-0; 89-48-5; Symfresh RF / Menthylacetate);3-Hydroxy-2,2,4-trimethylpentyl-2-methylpropanoate (25265-77-4; Symfresh NX); (4-methyl-4-phenylpentan-2-yl) acetate (68083-58-9; Vertikolacetat); allyl amyl glycolate; allyl caproate; allylcyclohexylpropionate; allyl heptate; benzyl acetate; benzyl salicylate; citronellyl acetate; dimethylbenzylcarbyl acetate; dimethylbenzylcarbyl butyrate; ethyl butyrate; ethyl caproate; trans / cis-2,4-ethyldecanedienoate; ethyl-2-methylbutyrate; ethylene brassirate; geranyl acetate; helvylpropionate; cis / trans-3-hexenyl acetate; A tablet according to any one of claims 1 to 6, selected from the group of esters consisting of cis-3-hexenyl acetate; cis-3-hexenyl butyrate; cis-3-hexenyl isobutyrate; cis-3-hexenyl salicylate; hexyl acetate; hexyl butyrate; hexyl isobutyrate; hexyl salicylate; isoamyl acetate; isobornyl acetate; isobutyl acetate; isoeugenyl acetate; linalyl acetate; methyl octin carbonate; neryl acetate; phenylethyl butyrate; phenylethyl cinnamate; prenyl acetate; styral acetate; methyl anthranylate; and mixtures thereof.

8. The aforementioned fragrance or fragrance oil is (3aR,5aS,9aS,9bR)-3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran (6790-58-5; Ambroxide); 5-hexyl-4-methyloxolan-2-one (67663-01-8; Apriflo ren); cyclohexadeca-2-en-1-one (2550-59-6; 3100-36-5; 88642-03-9; Aurelione); 3,4-diethyl-2,5-dimethylcyclohexa-2-en-1-one (68845-36-3; Azarbre); 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hex A tablet according to any one of claims 1 to 7, selected from the group of ethers consisting of methylcyclopenta(g)-2-benzopyran(1222-05-5; Galaxolide); (2R,4S)-2-methyl-4-propyl-1,3-oxathian + 2-methyl-4-propyl-1,3-oxathian(59323-76-1,261-699-8; Oxane / Oxathia); 3,7'-dimethyl-3,4,4a,5,8,8a-hexahydrospiro-(1,4-methanonaphthalene-2(1H)-2'-oxirane)(41816-03-9; Rhubofix); anethole; lime oxide; nerolin yala yala; orange flower ether; and mixtures thereof.

9. The aforementioned fragrance or fragrance oil is 7-methyl-3,4-dihydro-2H-1,5-benzodioxepin-3-one (249-320-4; Calone); 1,2,3,5,6,7-hexahydro-1,1,2,3,3-pentamethyl-4H-inden-4-one (251-649-3; Cashmeran); [3R-(3α,3aβ,6α,7β,8aα)]-octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene + (3R,3aS,6R,7R,8aS)-octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene (19870-74-7; 67874-81-1; Cedramber); 3a,6,6,9a-tetramethyl-2,4,5,5a,7,8,9,9b-octahydro-1H-benzo[e][1]benzofuran (3738-00-9; Cetalox); 1-(5,5-dimethyl-1-cyclohexenyl)penta-4-en-1-one (56973-85-4; Dynascone, Galbascone); 1-[bis(2-hydroxypropyl)amino]propan-2-ol; 5-methyl Ruhepta-2-en-4-one (102322-83-8; 81925-81-7; Filbertone); 4-(4-hydroxyphenyl)butan-2-one (5471-51-2; Frambinon); (8E)-cyclohexadeca-8-en-1-one (3100-36-5; Globanone); 4-(2,5,6,6-tetramethylcyclohexa-2-enyl)buta-3-en-2-one (201-219-6; Alpha Irone); 1-(2,3,8,8-tetramethyl-1,3,4,5,6,7-hexahydronaphthalene-2-yl)ethanone (54464-57-2; Iso E Super); cyclohexadecanone (2550-52-9; Isomuscone); 5,5,9,13-tetramethyl-14,16-dioxatetracyclo[11.2.1.01,10.04,9]hexadecane (57345-19-4; Ketamber); 5-hexyl-5-methyloxolan-2-one (7011-83-8; Lactojasmone); (E)-3-methyl-4-(2,6,6-trimethyl-1-cyclohexa-2-enyl)buta-3-en-2-one (127-51-5; Methyl Ionone Gamma Coeur); N-1-(2,6,6-trimethyl-1-cyclohexa-2-enyl)penta-1-en-3-one (1335-46-2; Methyl Ionone Gamma Pure); (5E)-3-methylcyclopentadeca-5-en-1-one; (5E)-3-methylcyclopentadeca-5-en-1-one (63314-79-4; 82356-51-2; Muscenone); 3-methylcyclopentadecan-1-one (541-91-3; Muscone); 2-[2-(4-methyl-1-cyclohexa-3-enyl)propyl]cyclopentan-1-one (95962-14-4; Nectaryl); 1-(3-methyl-1-benzofuran-2-yl)ethane-1-one (23911-56-0; Nerolione); octahydro-7-methyl-1,4-methanonaphthalene-6(2H)-one (41724-19-0; Plicatone); 1-(3,5,5,6,8,8-hexamethyl-6,7-dihydronaphthalene-2-yl)ethane + 1-(3,5,5,6,8,8-hexamethyl-6,7-dihydronaphthalene-2-yl)ethane (1506-02-1; 21145-77-7; T A tablet according to any one of claims 1 to 8, selected from the group of ketones consisting of onalide; 2,2,5-trimethyl-5-pentylcyclopentan-1-one (65443-14-3; veloutone); damascenone; α-damascone; β-damascone; δ-damascone; β-dihydroionone; dihydrojasmone; ethylmaltol; γ-hexalactone; α-ionone; β-ionone; jasmine lactone; jasmolactone CNC; cis-jasmone; maltol; methylionone; and mixtures thereof.

10. The aforementioned fragrances or fragrance oils include 5-heptyloxolan-2-one (104-67-6; Aldehyde C14); 5-pentyloxolan-2-one (203-219-1; Aldehyde C18); (9Z)-17-oxacycloheptadeca-9-en-1-one (28645-51-4; Ambrettolide); (12E)-1-oxacyclohexadeca-12-en-2-one + (3E)-oxacyclohexadeca-3-en-2-one (111879-80-2; 34902-57-3; Globalide); and 16-oxacyclohexadecane-1-one (106-02-5; Supra A tablet according to any one of claims 1 to 9, selected from the group of lactones consisting of macrolide; δ-decalactone; γ-decalactone; γ-octaractone; rose oxide (high cis form); and mixtures thereof.

11. The aforementioned fragrance or fragrance oil is Ambrette seed (absolute); Amyris oil; Angelica root oil; Apricot seed oil; Artemisia oil; Basil oil; Bay oil; Beeswax (absolute); Benzoin resinoid; Bergamot oil; Boya; Cabreuba oil; Cade oil; Cananga oil (Java); Caraway oil; Cardamom (absolute) / Cardamom oil; Carrot seed oil; Cassia oil; Cassi (absolute) (Egypt); Blackcurrant (absolute) (Burgundy) (Yu); Castreum (absolute); Cedar leaf oil; Cedarwood oil; Cedarwood oil; Cedarwood oil (Atlas); Celery seed oil; Chamomile oil (blue); Chamomile oil (Roma); Cinnamon bark oil; Cinnamon leaf oil; Cistus labdanum (absolute) (SIS); Cistus oil; Citronella oil (Formosa / Java); Clary sage oil; Clove bud oil; Clove leaf oil; Coconut oil; Copaiba balsam oil; Coriander oil; Cumin oil; Cypress oil; cypriol oil; davana oil; dill weed oil; dynamon; elemi oil / elemi gum; tarragon oil; eucalyptus oil (citriodora); fennel oil (sweet); fir balsam (absolute); fucus (absolute); galbanum oil; geranium oil; ginger (absolute / ginger oil); grapefruit oil (white); guaiac wood oil; gurujun balsam oil; hay (absolute); hydrocarbonesin B Immortelle (absolute); Jasmine (absolute); Jasmine (absolute) (Sambac); Juniper berry oil (R.S); Labdanum (absolute) / Labdanum resinoid; Laurel (noble) leaf oil (FLS); Lavandin oil; Lavender oil (white); Lemon oil; Lemon oil (terpene); Lemon oil (winter); Lemongrass oil; Lentisque (absolute); Lime oil; Lime oil (terpene); Litsea Akbeba oil; Longoza oil; Lobaji root oil; Mace oil (distilled, low safflower); Mace oil; Magnolia flower oil; Magnolia leaf oil; Mandarin oil; Marjoram oil; Mentha arvensis oil; Mimosa (absolute); Mousse C (absolute); Myrrh oil; Myrtle oil; Narcissus (absolute); Neroli oil; Nutmeg oil; Olibanum oil; Opoponax oil / Opoponax resinoid; Orange flower extract; Orange oil; Origanum oil; Osmanthus ( (Absolute); Palmarosa oil; Parsley leaf oil; Parsley seed oil; Patchouli oil; Black pepper oil; Pepper oil / Pepper (absolute) (Sichuan type); Peppermint oil; Peruvian balsam oil; Petit brêne bigarade (absolute); Petitgrain oil (citronella); Pimento leaf oil; Pine needle (absolute); Pine needle oil; Pink pepper leaf oil; Red berry (absolute); Red berry oil; Rose (absolute); Rosemary oil; Rum CO ２ A composition according to any one of claims 1 to 10, selected from the group of essential oils and extracts comprising: extracts; sage (officinale) oil (Dalmatia); sandalwood oil; spearmint oil; spike oil; star anise oil; styrax oil; sweet almond oil; tagetes oil; tangerine slavon oil (Brazil); tea tree oil; tuja oil; thyme oil; timut pepper oil; tonka bean (absolute); tuberose (absolute); turmeric oil; turpentine oil; vanilla (absolute); vetiver oil / vetiver (absolute); violet leaf (absolute); wheat bran (absolute); wormwood oil; ylang-ylang oil; and mixtures thereof.

12. The tablet according to any one of claims 1 to 11, wherein the fragrance composition (b) does not contain ethanol.

13. The at least one solubilizing agent is C ５ -C １２ A tablet according to any one of claims 1 to 12, selected from 1,2-alkanediols.

14. The at least one solubilizing agent is C ５ -C １２ A tablet according to any one of claims 1 to 13, selected from alkyl glycosides.

15. The tablet according to any one of claims 1 to 14, wherein the at least one solubilizer is selected from PEG 40 hydrogenated castor oil, trideceth-9, polyglyceryl-6 caprylate, polysorbate 20, polysorbate 80, sodium cocoyl glutamate, polyglyceryl-6 oleate, sodium surfactant, polyglyceryl-4 caprate, and mixtures thereof.

16. The tablet according to any one of claims 1 to 15, wherein the at least one pH adjusting agent is selected from sodium chloride, citric acid, sodium benzoate, triethyl citrate, triethanolamine, potassium sorbate, aminocitric acid, and mixtures thereof.

17. A tablet according to any one of claims 1 to 16, comprising at least 35% by weight of a carrier.

18. A tablet according to any one of claims 1 to 17, comprising the carrier and the fragrance composition in a weight ratio of about 1:1 to about 1:

100.

19. (a) A carrier comprising approximately 35 to 55% by weight, preferably approximately 40 to 50% by weight; (b1) At least one fragrance ingredient in an amount of about 3 to about 20% by weight, preferably about 5 to about 15% by weight; (b2) at least one solubilizing agent in an amount of about 5 to about 25% by weight, preferably about 10 to about 22% by weight; and (b3) A tablet according to any one of claims 1 to 18, comprising or comprising at least one pH adjusting agent in an amount of about 15 to about 35% by weight, preferably about 20 to about 30% by weight, totaling 100% by weight.

20. A tablet according to any one of claims 1 to 19, wherein the weight ratio of the tablet to water is in the range of about 1:8 to about 1:8, preferably about 1:4 to about 2:7, and exhibits complete dissolution in 16 dH water at 20°C.

21. A method for producing a flavor tablet, comprising or consisting of the following steps: (a) A step of preparing a solid carrier; (b) A step of preparing a mixture of at least one fragrance ingredient, at least one solubilizer, and at least one pH adjuster; (c) Blending the compounds from steps (a) and (b) under stirring at a temperature in the range of approximately 30 to approximately 50°C; (d) A step of applying the mixture from step (c) to a mechanical press to obtain the final product.

22. The method according to claim 21, wherein the tablets thus obtained exhibit complete dissolution at 20°C in water with a hardness of 16 dH when the weight ratio of the tablets to water is in the range of about 1:8 to about 1:3, preferably about 1:5 to about 2:

7.

23. Use of the tablet according to any one of claims 1 to 20 for personal care purposes.

Images